93 223
Pill imprint 93 223 has been identified as Sumatriptan succinate 50 mg.
Sumatriptan is used in the treatment of migraine; cluster headaches; new daily persistent headache; cyclic vomiting syndrome and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy.
Sumatriptan 50 mg is not subject to the Controlled Substances Act.
See also related documents.
Sumatriptan succinate Images
- Imprint:
-
93
223 - Strength:
- 50 mg
- Color:
- White
- Size:
- 14.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
hypromellose
lactose anhydrous
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol
titanium dioxide
- Drug Class:
- Antimigraine agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-0223
| NDC Code | Manufacturer / Repackager |
|---|---|
| 66267-1264 | Nucare Pharmaceuticals Inc (repackager) |
| 54569-6126 | A S Medication Solutions LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Sumatriptan Succinate resources
- Sumatriptan (Wolters Kluwer)
- Sumatriptan Spray (Wolters Kluwer)
- Sumatriptan Tablets (Wolters Kluwer)
- sumatriptan injection (Cerner Multum)
- sumatriptan oral/nasal (Cerner Multum)
- Imitrex Stat Dose Refill (Micromedex) - Includes Dosage Information
- Imitrex Stat Dose Refill Subcutaneous (Micromedex) - Includes Dosage Information
- sumatriptan (Micromedex) - Includes Dosage Information
- sumatriptan Nasal, Oral, Subcutaneous (Micromedex) - Includes Dosage Information
- sumatriptan Subcutaneous (Micromedex) - Includes Dosage Information
- Sumatriptan (AHFS DI)
- Sumatriptan Succinate (AHFS DI)
- Imitrex Injection (FDA)
- Imitrex Nasal Spray (FDA)
- Sumatriptan (FDA)
- Sumatriptan Injection (FDA)
- Sumatriptan Nasal Spray (FDA)
- Sumatriptan (Wolters Kluwer)
Search Again
